Home / Uncategorized / Avastin unlikely to get ovarian cancer approval after disappointing studies

Avastin unlikely to get ovarian cancer approval after disappointing studies

Posted by: Philippe Matthews in Uncategorized Comments Off on Avastin unlikely to get ovarian cancer approval after disappointing studies 270 Views

Avastin gave more side effects, did not improve survival for most ovarian cancer patients

Link:
Avastin unlikely to get ovarian cancer approval after disappointing studies

If you enjoyed this post, make sure you subscribe to my RSS feed!

Tagged with:

About Philippe Matthews

© 2014 the PM show – If You Like O, You Will Love P. All Rights Reserved. |A My Internet Marketing Expert Production
Scroll To Top